Skip to main content
Clinical Trials/NCT05540392
NCT05540392Active, not recruitingPhase 1

Nocturia in Prostate Cancer Survivors - Acupuncture Pilot Study (NOCTURNAL)

Memorial Sloan Kettering Cancer Center15 sites in 1 country60 target enrollmentStarted: September 9, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Enrollment
60
Locations
15
Primary Endpoint
success

Study Overview

Brief Summary

The purpose of this study is to test whether acupuncture can improve nocturia in prostate cancer survivors. This is the first time acupuncture is being studied for nocturia in prostate cancer survivors. Researchers will see if acupuncture is a practical treatment option for prostate cancer survivors with nocturia. The study will also look at the effect acupuncture has on nocturia and other symptoms prostate cancer survivors experience such as insomnia, hot flashes, anxiety, depression, tiredness (fatigue), sexual dysfunction, and cognitive (mental) difficulties.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age 18 or older
  • •Prior PC diagnosis
  • •No evidence of Prostate Cancer
  • •Clinically meaningful nocturia, defined as ≥2 nocturia episodes every night for the past month

Exclusion Criteria

  • •<1 month since completion of PC treatment (surgery, chemotherapy, radiation, ADT)
  • •Score of ≥5 on the STOP-Bang questionnaire indicative of high risk of moderate-to severe obstructive sleep apnea
  • •Other untreated primary sleep disorder (e.g. delayed/advanced sleep phase syndrome)
  • •Untreated primary psychiatric disorder (e.g. bipolar disorder, schizophrenia, substance abuse, dementia)
  • •Initiation of new medications for urinary symptoms in the past 4 weeks
  • •Altered dosing of medications for urinary symptoms in the past 4 weeks
  • •Plan to initiate/change medications or other treatments (e.g. surgery, behavioral intervention, complementary therapies) for urinary symptoms during the study
  • •Implanted electronically charged medical device
  • •Unable to provide consent for himself
  • •Unwilling to adhere to all study-related procedures

Arms & Interventions

Acupuncture

Experimental

Acupuncture group will receive 10 treatments of acupuncture over the course of 10 weeks (i.e. one treatment a week) with a +/- 14-day window.

Intervention: Acupuncture (Procedure)

Acupuncture

Experimental

Acupuncture group will receive 10 treatments of acupuncture over the course of 10 weeks (i.e. one treatment a week) with a +/- 14-day window.

Intervention: Questionnaires (Other)

Waitlist Control

Experimental

The waitlist control group will not receive any acupuncture treatments during the 14-week waiting period. Patients in waitlist control group will have the option to receive up to 10 acupuncture treatments after a 14-week waiting period.

Intervention: Questionnaires (Other)

Waitlist Control

Experimental

The waitlist control group will not receive any acupuncture treatments during the 14-week waiting period. Patients in waitlist control group will have the option to receive up to 10 acupuncture treatments after a 14-week waiting period.

Intervention: Waitlist Control (Other)

Outcomes

Primary Outcomes

success

Time Frame: 1 year

If a participant completes at least 8 out of 10 acupuncture sessions. Feasibility will be evaluated based on the respective definitions of success for the acupuncture.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (15)

Loading locations...

Similar Trials